Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IMC-2034 by ImmuneCyte for Premature Ovarian Failure: Likelihood of Approval
IMC-2034 is under clinical development by ImmuneCyte and currently in Phase I for Premature Ovarian Failure. According to GlobalData, Phase...
IMC-2017 by ImmuneCyte for Spinal Cord Disorders: Likelihood of Approval
IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase...
IMC-2032 by ImmuneCyte for Premature Ageing: Likelihood of Approval
IMC-2032 is under clinical development by ImmuneCyte and currently in Phase I for Premature Ageing. According to GlobalData, Phase I...
IMC-2015 by ImmuneCyte for Osteonecrosis: Likelihood of Approval
IMC-2015 is under clinical development by ImmuneCyte and currently in Phase I for Osteonecrosis. According to GlobalData, Phase I drugs...